{"id":"direct-iv-injection","safety":{"commonSideEffects":[{"rate":"1-5%","effect":"Pneumonitis"},{"rate":"1-5%","effect":"Hypothyroidism"},{"rate":"1-5%","effect":"Diarrhea"},{"rate":"1-5%","effect":"Fatigue"},{"rate":"1-5%","effect":"Nausea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By binding to PD-1, the drug prevents cancer cells from evading the immune system, allowing the body's immune cells to attack and destroy the cancer cells. This leads to an anti-tumor response and potentially prolonged survival in patients with certain types of cancer.","oneSentence":"This drug targets the PD-1 receptor to inhibit cancer cell growth.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:09:37.115Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Non-small cell lung cancer, PD-L1 positive"},{"name":"Head and neck squamous cell carcinoma"}]},"trialDetails":[{"nctId":"NCT05652504","phase":"PHASE1","title":"Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)","status":"SUSPENDED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-04-01","conditions":"Malaria","enrollment":400},{"nctId":"NCT05114746","phase":"PHASE2","title":"Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2022-01-25","conditions":"Prostate Cancer","enrollment":87},{"nctId":"NCT07195331","phase":"PHASE4","title":"Comparison Between Standard and Reduced Doses of Indocyanine Green in Fluorescence Cholangiography During Laparoscopic Cholecystectomy.","status":"RECRUITING","sponsor":"Instituto de Investigación Biomédica de Salamanca","startDate":"2026-02-26","conditions":"Laparoscopic Cholecystectomy Surgery","enrollment":122},{"nctId":"NCT06918808","phase":"PHASE2","title":"DB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn's Disease","status":"RECRUITING","sponsor":"Direct Biologics, LLC","startDate":"2025-05-19","conditions":"Perianal Fistula Due to Crohn's Disease","enrollment":36},{"nctId":"NCT05498428","phase":"PHASE2","title":"A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2022-11-11","conditions":"Carcinoma, Non-small-Cell Lung","enrollment":520},{"nctId":"NCT07372352","phase":"PHASE2","title":"Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCL","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2026-01-15","conditions":"Peripheral T Cells Lymphoma (PTCL)","enrollment":26},{"nctId":"NCT05085873","phase":"PHASE4","title":"Sodium Oxybate Versus Midazolam for Comfort Sedation","status":"COMPLETED","sponsor":"Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer","startDate":"2021-10-14","conditions":"Palliative Care","enrollment":22},{"nctId":"NCT07360548","phase":"PHASE2","title":"Study of 18FET PET in Functional Pituitary Adenomas With Indeterminate MRI Findings","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Lille","startDate":"2026-03","conditions":"Functional Pituitary Adenomas","enrollment":30},{"nctId":"NCT06736379","phase":"PHASE1","title":"Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer","status":"RECRUITING","sponsor":"VLP Therapeutics","startDate":"2025-05-13","conditions":"Head and Neck Cancers- Squamous Cell, Head and Neck Cancer, Solid Tumors","enrollment":41},{"nctId":"NCT07285980","phase":"NA","title":"Comparison of Bier Block and Lidocaine-Propofol Mixture for Prevention of Propofol Injection Pain","status":"COMPLETED","sponsor":"Asma Ladib","startDate":"2025-03-01","conditions":"Propofol Injection Pain","enrollment":180},{"nctId":"NCT03983850","phase":"PHASE1, PHASE2","title":"Optimizing PTCy Dose and Timing","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-07-09","conditions":"Graft Versus Host Disease, Hematologic Neoplasms","enrollment":105},{"nctId":"NCT07233213","phase":"PHASE3","title":"An Open-label Study of Intravenous Immunoglobulin (5%) for the Treatment of Primary Immune Thrombocytopenia","status":"RECRUITING","sponsor":"Grand Shuyang Life Sciences (Chengdu) Co., Ltd.","startDate":"2025-11-24","conditions":"Primary Immune Thrombocytopenia (ITP)","enrollment":36},{"nctId":"NCT03823144","phase":"NA","title":"Intravital Microscopy in Human Solid Tumors","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2019-02-28","conditions":"Solid Tumor, Adult, Clinical Stage IV Gastric Cancer AJCC v8, Malignant Solid Neoplasm","enrollment":85},{"nctId":"NCT06733129","phase":"PHASE3","title":"Best Hypnotic Drug Choice for Rapid Sequence Induction in the Operating Room","status":"RECRUITING","sponsor":"Nantes University Hospital","startDate":"2025-04-14","conditions":"Rapid Sequence Induction","enrollment":1218},{"nctId":"NCT04725331","phase":"PHASE1, PHASE2","title":"A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors","status":"TERMINATED","sponsor":"Transgene","startDate":"2021-02-25","conditions":"Metastatic Cancer, Soft Tissue Sarcoma, Merkel Cell Carcinoma","enrollment":31},{"nctId":"NCT04316611","phase":"PHASE2","title":"Potassium Chloride in Out-of-hospital Cardiac Arrest Due to Refractory Ventricular Fibrillation","status":"WITHDRAWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-12","conditions":"Out-of-hospital Cardiac Arrest (OHCA)","enrollment":""},{"nctId":"NCT04796194","phase":"PHASE2","title":"Intratumoral Injection of LTX-315 in Combination With Pembrolizumab in Advanced Melanoma","status":"COMPLETED","sponsor":"Lytix Biopharma AS","startDate":"2021-06-01","conditions":"Advanced Melanoma","enrollment":23},{"nctId":"NCT07154979","phase":"NA","title":"Oliceridine Dose for Tracheal Intubation Hemodynamic Elevation: Up-and-Down Trial","status":"COMPLETED","sponsor":"Shiyou Wei","startDate":"2025-09-04","conditions":"Oliceridine","enrollment":58},{"nctId":"NCT06881927","phase":"PHASE4","title":"Eduction in ImmunoSuppressive Regimen Among Kidney Transplant Recipients Patients Admitted to the Intensive Care Unit for Septic Shock and/or Acute Respiratory Failure","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Strasbourg, France","startDate":"2026-02-01","conditions":"Sepsis and Septic Shock, Acute Respiratory Failure, Kidney Transplant Recipients","enrollment":212},{"nctId":"NCT07178938","phase":"PHASE2","title":"Platform Trial Assessing Uptake, Safety and Efficacy of Theranostic Agents in Solid Tumors With Active Brain Metastases","status":"NOT_YET_RECRUITING","sponsor":"MedSIR","startDate":"2026-04-30","conditions":"Solid Tumors, HER2-positive Breast Cancer","enrollment":10},{"nctId":"NCT03694756","phase":"NA","title":"TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer","status":"RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2018-12-12","conditions":"Breast Cancer","enrollment":95},{"nctId":"NCT02332447","phase":"PHASE3","title":"Efficacy of Naloxone in Reducing Postictal Central Respiratory Dysfunction in Patients With Epilepsy","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2015-06-26","conditions":"Epilepsy","enrollment":485},{"nctId":"NCT04369937","phase":"PHASE2","title":"HPV-16 Vaccination and Pembrolizumab Plus Cisplatin for \"Intermediate Risk\" HPV-16-associated Head and Neck Squamous Cell Carcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dan Zandberg","startDate":"2020-07-06","conditions":"HPV-Related Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma","enrollment":18},{"nctId":"NCT03727555","phase":"NA","title":"IT and IV Lentiviral Gene Therapy for X-ALD","status":"RECRUITING","sponsor":"Shenzhen Geno-Immune Medical Institute","startDate":"2025-08-31","conditions":"X-linked Adrenoleukodystrophy","enrollment":30},{"nctId":"NCT03217617","phase":"PHASE1, PHASE2","title":"SCID-X1 Gene Therapy Via Intravenous Lentiviral (Ivlv-X1) Injection","status":"RECRUITING","sponsor":"Shenzhen Geno-Immune Medical Institute","startDate":"2024-06-30","conditions":"SCID, X-Linked","enrollment":10},{"nctId":"NCT03645460","phase":"NA","title":"Gene Therapy for ADA-SCID Using an Improved Lentiviral Vector (Ivlv-ADA)","status":"RECRUITING","sponsor":"Shenzhen Geno-Immune Medical Institute","startDate":"2024-06-30","conditions":"Adenosine DeAminase Severe Combined ImmunoDeficiency (ADA-SCID)","enrollment":10},{"nctId":"NCT07122089","phase":"PHASE2","title":"Evaluation of SIRT Followed by Immunotherapy for Treatment of Hepatocellular Carcinoma With Portal Vein Thrombosis","status":"NOT_YET_RECRUITING","sponsor":"Center Eugene Marquis","startDate":"2026-01-02","conditions":"Hepatocellular Carcinoma Non-resectable","enrollment":80},{"nctId":"NCT06689917","phase":"NA","title":"JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2025-01-20","conditions":"B-ALL, B-NHL","enrollment":20},{"nctId":"NCT03725670","phase":"NA","title":"Direct Lentiviral Injection Gene Therapy for MLD","status":"RECRUITING","sponsor":"Shenzhen Geno-Immune Medical Institute","startDate":"2025-05-31","conditions":"Metachromatic Leukodystrophy (MLD)","enrollment":10},{"nctId":"NCT03315871","phase":"PHASE2","title":"Combination Immunotherapy in Biochemically Recurrent Prostate Cancer","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2018-03-20","conditions":"Prostate Cancer","enrollment":40},{"nctId":"NCT03432741","phase":"PHASE1","title":"Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2018-03-27","conditions":"Breast Adenocarcinoma, Metastatic Breast Carcinoma, Recurrent Breast Carcinoma","enrollment":17},{"nctId":"NCT06600880","phase":"PHASE1","title":"Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau","status":"NOT_YET_RECRUITING","sponsor":"Columbia University","startDate":"2026-08","conditions":"Alzheimer Disease, Early Onset","enrollment":6},{"nctId":"NCT04301011","phase":"PHASE1","title":"Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors","status":"TERMINATED","sponsor":"Turnstone Biologics, Corp.","startDate":"2020-06-02","conditions":"Solid Tumor, Microsatellite Stable Colorectal Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma","enrollment":27},{"nctId":"NCT04317872","phase":"NA","title":"Effect of Peri-operative Glucocorticoids on Short-term Functional Outcome After THA","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2020-07-01","conditions":"Coxarthrosis, Avascular Necrosis of Hip","enrollment":71},{"nctId":"NCT06444815","phase":"PHASE1","title":"A Study of VET3-TGI in Patients With Solid Tumors","status":"RECRUITING","sponsor":"KaliVir Immunotherapeutics","startDate":"2024-09-16","conditions":"Solid Tumor, Adult, Microsatellite Stable Colorectal Cancer, Head and Neck Squamous Cell Carcinoma","enrollment":60},{"nctId":"NCT03029026","phase":"","title":"The Role of Occult Cardiac Amyloid in the Elderly With Aortic Stenosis.","status":"COMPLETED","sponsor":"Queen Mary University of London","startDate":"2011-02-22","conditions":"Cardiac Amyloidosis, Aortic Stenosis","enrollment":581},{"nctId":"NCT06861374","phase":"NA","title":"Bivalirudin with Prolonged Infusion During PCI Versus Heparin After Fibrinolytic Therapy","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2025-05","conditions":"ST-segment Elevation Myocardial Infarction (STEMI)","enrollment":2400},{"nctId":"NCT06611891","phase":"PHASE3","title":"Evaluation of Somatostatin Receptor Expression in PET 68Ga-DOTATOC in Patients Followed for Metastatic Breast Cancer","status":"RECRUITING","sponsor":"University Hospital, Grenoble","startDate":"2025-01-06","conditions":"Breast Cancer Metastatic","enrollment":25},{"nctId":"NCT06786507","phase":"","title":"A Direct Head-to-head Comparison of Ustekinumab with Infliximab for the Treatment of Ulcerative Colitis","status":"NOT_YET_RECRUITING","sponsor":"Helwan University","startDate":"2025-05-15","conditions":"Ulcerative Colitis (UC)","enrollment":100},{"nctId":"NCT05932641","phase":"PHASE1","title":"Study of AZD3152 Intramuscular Injection or Intravenous Infusion in Healthy Japanese Adult Participants","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2023-07-31","conditions":"COVID-19, SARS-CoV-2","enrollment":24},{"nctId":"NCT06737939","phase":"NA","title":"Periprostatic Nerve Block vs. Intravenous Ibuprofen for Pain Management During Transrectal Prostate Biopsy","status":"COMPLETED","sponsor":"University of Gaziantep","startDate":"2023-06-01","conditions":"Pain, Acute","enrollment":128},{"nctId":"NCT06352632","phase":"PHASE3","title":"ACT-GLOBAL Adaptive Platform Trial for Stroke","status":"RECRUITING","sponsor":"The George Institute","startDate":"2024-09-26","conditions":"Stroke","enrollment":20000},{"nctId":"NCT04313868","phase":"PHASE1","title":"GEN2 Directed Cancer Immunotherapy Trial","status":"COMPLETED","sponsor":"GenVivo, Inc.","startDate":"2014-06-13","conditions":"Hepatocellular Carcinoma, Metastatic Cancer","enrollment":61},{"nctId":"NCT06651151","phase":"PHASE2","title":"NeoLIPA: Neoadjuvant LTX-315 in Combination with Pembrolizumab in Resectable Stage III/IV Melanoma","status":"RECRUITING","sponsor":"Oslo University Hospital","startDate":"2024-11-01","conditions":"Melanoma Stage IIIB-IV","enrollment":27},{"nctId":"NCT04507256","phase":"PHASE1","title":"AZD7442 - a Potential Combination Therapy for the Prevention and Treatment of COVID-19","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2020-08-18","conditions":"COVID-19","enrollment":60},{"nctId":"NCT06579274","phase":"PHASE2","title":"Evaluation of the Safety and Efficacy of Parecoxib in Patients With Subarachnoid Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"St. Anne's University Hospital Brno, Czech Republic","startDate":"2025-01-01","conditions":"Neurological Complication","enrollment":112},{"nctId":"NCT06509256","phase":"EARLY_PHASE1","title":"Different Methods of Tranexamic Acid Application in Controlling Peri Operative Bleeding in Gynecomastia Surgery","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-07-20","conditions":"Pharmacological-Aggravated Urticaria","enrollment":50},{"nctId":"NCT03952065","phase":"PHASE2, PHASE3","title":"IT or IA Infusion of PD1/PDL1/CTLA4 Inhibitors Versus IV for Immunotherapy of Head/Neck Cancers (HNC)","status":"RECRUITING","sponsor":"Second Affiliated Hospital of Guangzhou Medical University","startDate":"2019-01-01","conditions":"Head/Neck Neoplasm","enrollment":200},{"nctId":"NCT05622162","phase":"PHASE3","title":"Prospective Comparative Study for Patients With Biochemical Recurrence Prostate Cancer Detecting by 18F-JK-PSMA-7","status":"ACTIVE_NOT_RECRUITING","sponsor":"ITEL Telecomunicazioni Srl","startDate":"2022-12-19","conditions":"Prostate Cancer, 18F- Fluorocholine, PSMA PET","enrollment":106},{"nctId":"NCT06417268","phase":"PHASE2","title":"Combined Pericapsular Nerve Group Block and Lateral Femoral Cutaneous Nerve Block for Pediatric Hip Surgeries","status":"RECRUITING","sponsor":"Kasr El Aini Hospital","startDate":"2024-03-01","conditions":"Pericapsular Nerve Group Block","enrollment":68},{"nctId":"NCT03256344","phase":"PHASE1","title":"Study of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases","status":"COMPLETED","sponsor":"Amgen","startDate":"2018-03-19","conditions":"Metastatic Triple Negative Breast Cancer, Metastatic Colorectal Cancer","enrollment":36},{"nctId":"NCT06128122","phase":"NA","title":"Dextrose Concentration Decline Rate in Vivo","status":"COMPLETED","sponsor":"Dr. Dean Reeves Clinic","startDate":"2023-12-19","conditions":"Dextrose Concentration","enrollment":1},{"nctId":"NCT04288518","phase":"PHASE1, PHASE2","title":"Molecular Imaging of Brain Tumors Using Labeled Technetium-99m 1-Thio-D-Glucose.","status":"COMPLETED","sponsor":"Tomsk National Research Medical Center of the Russian Academy of Sciences","startDate":"2020-02-15","conditions":"Brain, Neoplasms","enrollment":16},{"nctId":"NCT06081673","phase":"PHASE2","title":"Penpulimab Combined With Chemotherapy for Neoadjuvant and Adjuvant Therapy in Patients With Resectable HNSCC","status":"RECRUITING","sponsor":"Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University","startDate":"2023-10-30","conditions":"Head and Neck Squamous Cell Carcinoma","enrollment":72},{"nctId":"NCT04608812","phase":"PHASE1","title":"Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection","status":"TERMINATED","sponsor":"OncoSynergy, Inc.","startDate":"2021-03-02","conditions":"Glioma, Malignant, High Grade Glioma, Glioblastoma","enrollment":7},{"nctId":"NCT05976906","phase":"PHASE1","title":"Universal Dual-target NKG2D-NKp44 CAR-T Cells in Advanced Solid Tumors","status":"UNKNOWN","sponsor":"Zhejiang University","startDate":"2023-05-23","conditions":"Advanced Solid Tumors","enrollment":36},{"nctId":"NCT05487651","phase":"PHASE1","title":"Allogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell Malignancies","status":"UNKNOWN","sponsor":"Athenex, Inc.","startDate":"2022-10-01","conditions":"NHL, Relapsed, Adult, B-cell Lymphoma, B-cell Leukemia","enrollment":36},{"nctId":"NCT05801393","phase":"","title":"HRCT, CT Cisternography and MR Cisternography in Assessment of CSF Rhinorrhea","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2023-05-01","conditions":"Imaging of Active CSF Rhinorrhea","enrollment":50},{"nctId":"NCT05437289","phase":"PHASE1","title":"A Study to Evaluate the Safety and Tolerability of AZD7442 in Healthy Chinese Adults","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2021-10-09","conditions":"Coronavirus Disease 2019 (COVID-19), Healthy Volunteer","enrollment":61},{"nctId":"NCT05376540","phase":"NA","title":"Norwegian Randomized Trial on Indocyanine Green Cholangiography Utility for Laparoscopic Cholecystectomy, Prestudy","status":"UNKNOWN","sponsor":"Ostfold Hospital Trust","startDate":"2023-03-03","conditions":"Gall Stone, Cholecystitis","enrollment":100},{"nctId":"NCT02102243","phase":"PHASE4","title":"Neural Mechanism of Aldosterone-induced Insulin Resistance","status":"WITHDRAWN","sponsor":"Wanpen Vongpatanasin","startDate":"2010-11","conditions":"Hypertension","enrollment":""},{"nctId":"NCT05729308","phase":"NA","title":"Comparative Study Between Caudal Epidural Block and Bilateral Erector Spinae Plane Block in Lumbosacral Spine Surgeries.","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2023-02","conditions":"Postoperative Pain, Acute","enrollment":78},{"nctId":"NCT05647408","phase":"NA","title":"Evaluation of the Bioavailability of Dexamethasone in Healthy Subjects","status":"COMPLETED","sponsor":"Universidad Nacional Autonoma de Mexico","startDate":"2021-11-05","conditions":"Dexamethasone Administration, Intranasal Administration, Inflammation","enrollment":8},{"nctId":"NCT03809481","phase":"PHASE3","title":"Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban","status":"TERMINATED","sponsor":"Aspen Global Incorporated","startDate":"2019-05-16","conditions":"Heparin-induced Thrombocytopenia","enrollment":7},{"nctId":"NCT01810016","phase":"PHASE1","title":"NY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic Melanoma","status":"TERMINATED","sponsor":"Ludwig Institute for Cancer Research","startDate":"2014-01-24","conditions":"Unresectable or Metastatic Melanoma","enrollment":8},{"nctId":"NCT04459377","phase":"PHASE4","title":"Ketamine Analgesia in Third Molar Surgery","status":"COMPLETED","sponsor":"Dalarna County Council, Sweden","startDate":"2017-02-14","conditions":"Pain, Postoperative","enrollment":168},{"nctId":"NCT04769414","phase":"PHASE2","title":"Flouro-Gem in Adenocarcinoma of the Pancreas (GEFLUPAN)","status":"COMPLETED","sponsor":"Menoufia University","startDate":"2021-02-20","conditions":"Cancer of Pancreas, Chemotherapy Effect, Metastatic Pancreatic Cancer","enrollment":48},{"nctId":"NCT04490096","phase":"PHASE1","title":"Multimodal Imaging Outcome Measures for ALS (Image ALS)","status":"TERMINATED","sponsor":"University of Pennsylvania","startDate":"2021-02-25","conditions":"ALS","enrollment":2},{"nctId":"NCT03984045","phase":"PHASE3","title":"SPG Block for Acute Pediatric Migraine","status":"UNKNOWN","sponsor":"Newark Beth Israel Medical Center","startDate":"2019-06-06","conditions":"Migraine in Children, Sphenopalatine Neuralgia, Migraine in Adolescence","enrollment":72},{"nctId":"NCT05031676","phase":"NA","title":"Opioid Free Anesthesia in Maxillofacial Surgery","status":"COMPLETED","sponsor":"Université NAZI BONI","startDate":"2019-02-15","conditions":"Maxillofacial Surgery","enrollment":66},{"nctId":"NCT04477525","phase":"PHASE2","title":"The Feasibility of Performing Erector Spinae (ESP) Nerve Block in Bariatric Patients; a Case Series Study","status":"WITHDRAWN","sponsor":"Montefiore Medical Center","startDate":"2021-06-22","conditions":"Nerve Pain","enrollment":""},{"nctId":"NCT04292626","phase":"PHASE1","title":"Molecular Imaging of Lymphoma Using Labeled Technetium-99m 1-Thio-D-Glucose","status":"COMPLETED","sponsor":"Tomsk National Research Medical Center of the Russian Academy of Sciences","startDate":"2020-01-19","conditions":"Hodgkin Lymphoma, Adult, Non-Hodgkin Lymphoma, Adult","enrollment":16},{"nctId":"NCT03082456","phase":"NA","title":"Molecular Breast Imaging in Screening Breast Cancer","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2015-06-01","conditions":"Breast Cancer","enrollment":164},{"nctId":"NCT02953938","phase":"PHASE4","title":"Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2016-12-15","conditions":"Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)","enrollment":59},{"nctId":"NCT03564054","phase":"NA","title":"Trial of Photodynamic Therapy Versus Argon Plasma Coagulation for Lung Cancer With Endobronchial Obstruction","status":"TERMINATED","sponsor":"University of Florida","startDate":"2018-10-11","conditions":"Non Small Cell Lung Cancer","enrollment":3},{"nctId":"NCT04178109","phase":"PHASE2","title":"Oral Use of Dexketoprofen/Tramadol for Acute Postoperative Pain in Total Hip Replacement With a Direct Anterior Approach.","status":"COMPLETED","sponsor":"KAT General Hospital","startDate":"2019-01-10","conditions":"Postoperative Pain, Pain, Acute","enrollment":226},{"nctId":"NCT01364090","phase":"PHASE4","title":"A Collaborative Trial in Injectors of Individualized Treatment for Genotype 2/3","status":"COMPLETED","sponsor":"Kirby Institute","startDate":"2012-06","conditions":"Hepatitis C, Chronic","enrollment":93},{"nctId":"NCT04092621","phase":"PHASE4","title":"Rapid Atrial Fibrillation Treatment Strategy","status":"UNKNOWN","sponsor":"Our Lady of the Lake Hospital","startDate":"2019-09-16","conditions":"New Onset Atrial Fibrillation, Sepsis, Respiratory Failure","enrollment":40},{"nctId":"NCT04063293","phase":"EARLY_PHASE1","title":"PRP Injection Into Anal Sphincters for Fecal Incontinence","status":"UNKNOWN","sponsor":"Istanbul Medipol University Hospital","startDate":"2019-05-15","conditions":"Fecal Incontinence","enrollment":20},{"nctId":"NCT02558556","phase":"NA","title":"FALCON: a Multicenter Randomized Controlled Trial","status":"UNKNOWN","sponsor":"Maastricht University Medical Center","startDate":"2016-01","conditions":"Cholecystolithiasis, Cholecystitis","enrollment":308},{"nctId":"NCT03743974","phase":"NA","title":"Analgesic Efficacy of US-Guided Interscalene Block Versus Supraclavicular Block for Ambulatory Arthroscopic Rotator Cuff Repair","status":"COMPLETED","sponsor":"Ramsay Générale de Santé","startDate":"2016-10-03","conditions":"Shoulder Lesions","enrollment":108},{"nctId":"NCT01238276","phase":"","title":"Direct Antibiotic Delivery of Cefazolin Into Soft Tissue Infections Using Subcutaneous Injection and Ultrasonic Dispersion","status":"NO_LONGER_AVAILABLE","sponsor":"Sonescence, Inc.","startDate":"","conditions":"Infection, Soft Tissue, Infection, Wound, Cellulitis","enrollment":""},{"nctId":"NCT02011490","phase":"PHASE1","title":"Pharmacokinetics of Sugammadex (MK-8616) in Participants With Moderate and Severe Renal Insufficiency (MK-8616-105)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2013-12-11","conditions":"Renal Insufficiency, Renal Impairment","enrollment":33},{"nctId":"NCT02083432","phase":"NA","title":"Cognitive Behavioural Treatment of Intra-oral Injection-phobia in 10-16 Year Old Children and Adolescents","status":"COMPLETED","sponsor":"University of Bergen","startDate":"2013-12","conditions":"Dental Anxiety","enrollment":60},{"nctId":"NCT02698228","phase":"PHASE4","title":"Regional Anaesthesia for Painful Injuries After Disasters","status":"WITHDRAWN","sponsor":"Epicentre","startDate":"2016-03","conditions":"Lower Limb Injuries, Fracture","enrollment":""},{"nctId":"NCT02278510","phase":"EARLY_PHASE1","title":"Topotecan Using Convection-Enhanced Delivery (CED) in High Grade Glioma","status":"COMPLETED","sponsor":"Michael Vogelbaum, MD, PhD","startDate":"2014-12-09","conditions":"Malignant Glioma, WHO Grade III or IV Recurrent Glioma","enrollment":3},{"nctId":"NCT01721785","phase":"","title":"Diagnostic Value of Novel MR Imaging Techniques for the Primary Staging and Restaging of Rectal Cancer","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2012-10","conditions":"Rectal Neoplasms, Magnetic Resonance Imaging, Neoplasms Staging","enrollment":307},{"nctId":"NCT01207765","phase":"PHASE2","title":"Zevalin for Patients With Incomplete Response to Chemo Prior to Autologous Stem Cell Transplant for Multiple Myeloma","status":"TERMINATED","sponsor":"Tufts Medical Center","startDate":"2008-04","conditions":"Multiple Myeloma","enrollment":8},{"nctId":"NCT00072098","phase":"PHASE1","title":"Interleukin-12 Gene in Treating Patients With Liver Metastases Secondary to Colorectal Cancer","status":"TERMINATED","sponsor":"Max Sung","startDate":"2003-09","conditions":"Colorectal Cancer, Metastatic Cancer","enrollment":22},{"nctId":"NCT02186158","phase":"PHASE2","title":"Interest of Ascorbic Acid in the Management of Pneumonia in Elderly People Hospitalized.","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2015-02","conditions":"Pneumonia With Hospitalized Elderly Patient","enrollment":9},{"nctId":"NCT02870673","phase":"PHASE2, PHASE3","title":"Assessment of the Effectiveness of Ultrasound-guided Acupuncture in the Management of Carpal Tunnel Syndrome","status":"UNKNOWN","sponsor":"Taipei Medical University Hospital","startDate":"2016-08","conditions":"Carpal Tunnel Syndrome","enrollment":72},{"nctId":"NCT02733952","phase":"PHASE3","title":"Intravenous Tranexamic Acid Versus Pericervical Tourniquet To Decrease Blood Loss In Trans-Abdominal Myomectomy","status":"UNKNOWN","sponsor":"Ain Shams Maternity Hospital","startDate":"2015-08","conditions":"Post Operative Hemorrhage","enrollment":70},{"nctId":"NCT02283203","phase":"PHASE4","title":"A New Formulation of Intravenous Paracetamol for Fever Management","status":"COMPLETED","sponsor":"Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.","startDate":"2015-02","conditions":"Fever","enrollment":80},{"nctId":"NCT02170207","phase":"","title":"Takepron Intravenous 30 mg Specified Drug-use Survey [Acute Stress Ulcer and Acute Gastric Mucosal Lesions]","status":"COMPLETED","sponsor":"Takeda","startDate":"2007-01","conditions":"Acute Stress Ulcer and Acute Gastric Mucosal Lesions","enrollment":63},{"nctId":"NCT02151786","phase":"","title":"Lansoprazole Intravenous 30 mg Specified Drug-use Survey [Hemostatic Effect/Rebleeding Rate]","status":"COMPLETED","sponsor":"Takeda","startDate":"2007-01","conditions":"Gastric Ulcer, Duodenal Ulcer, Acute Stress Gastritis, and Acute Gastric Mucosal Lesions","enrollment":1120},{"nctId":"NCT02306629","phase":"PHASE1","title":"Study to Compare Properties of Epratuzumab When Given as an Injection Under the Skin or Directly Into the Blood","status":"COMPLETED","sponsor":"UCB Biopharma S.P.R.L.","startDate":"2014-11","conditions":"Systemic Lupus Erythematosus","enrollment":42},{"nctId":"NCT00799604","phase":"PHASE2","title":"Clevidipine Bolus Administration in the Treatment of Hypertensive Patients Undergoing Cardiac Surgery (SPRINT)","status":"COMPLETED","sponsor":"The Medicines Company","startDate":"2008-11","conditions":"Hypertension","enrollment":30},{"nctId":"NCT01416740","phase":"NA","title":"A Comparison of Indirect and Direct MR Arthrography of the Shoulder Using Arthroscopic Correlation","status":"WITHDRAWN","sponsor":"Milton S. Hershey Medical Center","startDate":"2009-12","conditions":"Shoulder Pain","enrollment":""},{"nctId":"NCT00005943","phase":"PHASE1","title":"Gene Therapy in Treating Patients With Metastatic Melanoma","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2000-02","conditions":"Melanoma (Skin)","enrollment":""},{"nctId":"NCT00929266","phase":"NA","title":"Cultured Red Blood Cells : Life Span in Vivo Study","status":"COMPLETED","sponsor":"Etablissement Français du Sang","startDate":"2010-05","conditions":"Healthy Volunteers","enrollment":1}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":7,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"direct IV injection","genericName":"direct IV injection","companyName":"Nantes University Hospital","companyId":"nantes-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This drug targets the PD-1 receptor to inhibit cancer cell growth. Used for Non-small cell lung cancer, PD-L1 positive, Head and neck squamous cell carcinoma.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}